Want to join the conversation?
Eric Handler from MKM Partners probes about 1Q16's lower CapEx versus 1Q15. $CNK said that the variance was due to the purchase of headquarters building in 1Q15. Timing wise, the company expects a bit of ramp up in CapEx over the next couple of quarters.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?